Massimo Fantini - Concepedia

Author

Massimo Fantini

Also Known As

Fantini, M.C., M C Fantini, M Fantini, M. C. Fantini, M. Fantini, M.C. Fantini, MASSIMO FANTINI, Massimo C Fantini, Massimo C. Fantini, Massimo Claudio Fantini

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

University of Rome Tor Vergata Center for Cancer Research National Institutes of Health National Cancer Institute Sapienza University of Rome

About

Massimo Fantini is an author at University of Rome Tor Vergata specializing in medicine, immunotherapy, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.6K
2	Cell Biology	4	4	1.3K
3	Public Health	1	1	62
4	Biomolecular Engineering	1	1	64
5	Cellular Physiology	1	1	180

Massimo Fantini

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth Veronica De Simone, Eleonora Franzè, Giulia Ronchetti, Oncogene Immune RegulationImmunologyPathologyImmunotherapyCancer Biology	2014	585
Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti–PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells Benjamin Boyerinas, Caroline Jochéms, Massimo Fantini, Cancer Immunology Research Pbmc SubsetsImmunologyImmunoeditingImmunotherapeuticsImmunotherapy	2015	452
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 Giovanni Monteleone, Roberta Caruso, Daniele Fina, Gut	2006	183
An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele Caroline Jochéms, James W. Hodge, Massimo Fantini, Oncotarget Lymphocyte DevelopmentImmunologyImmune RegulationImmunoeditingImmunologic Mechanism	2016	180
IL‐21 regulates experimental colitis by modulating the balance between T <sub>reg</sub> and Th17 cells Massimo Fantini, A.M. Rizzo, Daniele Fina, European Journal of Immunology	2007	162
The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells Caroline Jochéms, Massimo Fantini, Romaine I. Fernando, Oncotarget T-regulatory CellImmunologyImmune RegulationImmunoeditingImmunotherapeutics	2016	140
<i>In vitro</i>and<i>in vivo</i>inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors Monica Benvenuto, Laura Masuelli, Enrico De Smaele, Oncotarget	2016	111
Resveratrol potentiates the <i>in vitro</i> and <i>in vivo</i> anti-tumoral effects of curcumin in head and neck carcinomas Laura Masuelli, Enrica Di Stefano, Massimo Fantini, Oncotarget	2014	102
Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody Renee N. Donahue, Lauren M. Lepone, Italia Grenga, Journal for ImmunoTherapy of Cancer	2017	87
Curcumin blocks autophagy and activates apoptosis of malignant mesothelioma cell lines and increases the survival of mice intraperitoneally transplanted with a malignant mesothelioma cell line Laura Masuelli, Monica Benvenuto, Enrica Di Stefano, Oncotarget	2017	83

Page 1